[Form 4] Femasys Inc. Insider Trading Activity

Rhea-AI Filing Summary

Kathy Lee-Sepsick, Chief Executive Officer and Director of Femasys Inc. (FEMY), reported purchases in an underwritten public offering. On 08/27/2025 she acquired 48,535 Units at $0.5151 per Unit, where each Unit comprises one share of common stock and one warrant to purchase one share. After the transaction she beneficially owns 360,627 shares directly and 72,223 shares indirectly through the Lee-Sepsick Family Trust. The warrants are exercisable beginning 08/27/2025 and expire 08/27/2030.

Insights

Financial Analyst

TL;DR Insider purchase of Units combines immediate equity and detachable warrants, modestly increasing insider stake.

The filing documents a purchase by the CEO/director of 48,535 Units in an underwritten offering at $0.5151 each, with each Unit including one common share and one warrant exercisable through 08/27/2030. Post-transaction direct beneficial ownership is 360,627 shares, with an additional 72,223 shares held indirectly. The transaction is routine disclosure of insider participation in the offering and provides limited new financial metrics.

Corporate Governance Expert

TL;DR CEO participation in the offering shows alignment with the company but is a routine Form 4 disclosure.

The report confirms the reporting person serves as both CEO and a director and that the purchased Units were part of a registered offering (Form S-1 referenced). Ownership totals and indirect holdings through a family trust are disclosed, meeting Section 16 reporting obligations. The filing is a standard, timely insider report with clear signature and explanation of the Unit structure.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lee-Sepsick Kathy

(Last) (First) (Middle)

C/O FEMASYS INC.

3950 JOHNS CREEK COURT, SUITE 100

(Street)

SUWANEE GA 30024

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
FEMASYS INC [ FEMY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/27/2025		I		48,535	A	(1)	360,627	D
Common Stock								72,223	I	By the Lee-Sepsick Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Warrants (right to buy)	$0.5151	08/27/2025		I		48,535		08/27/2025	08/27/2030	Common Stock	48,535	(1)	48,535	D

Explanation of Responses:

1. The reported securities are included within 48,535 Units purchased by the reporting person for $0.5151 per Unit in an underwritten public offering pursuant to the Registration Statement on Form S-1 (File No. 333-289722). Each Unit consists of one share of common stock and one warrant to purchase one share of common stock.

	/s/ Kathy Lee-Sepsick	08/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did FEMY insider Kathy Lee-Sepsick purchase on 08/27/2025?

She purchased 48,535 Units at $0.5151 per Unit; each Unit includes one share of common stock and one warrant to buy one share.

How many FEMY shares does Kathy Lee-Sepsick beneficially own after the transaction?

She beneficially owns 360,627 shares directly and an additional 72,223 shares indirectly through the Lee-Sepsick Family Trust.

What are the terms of the warrants included with the Units?

Warrants have an exercise price tied to the Unit structure and are exercisable beginning 08/27/2025 with an expiration date of 08/27/2030.

Was the purchase part of a registered offering for FEMY?

Yes. The Units were purchased in an underwritten public offering pursuant to the Registration Statement on Form S-1 (File No. 333-289722).

Who signed the Form 4 and when was it signed?

Kathy Lee-Sepsick signed the Form 4 on 08/28/2025 as the reporting person.